Regenerative Pharmacology
This group focuses on fostering translational pharmacological projects, all the way from an initial discovery in experimental models to clinical studies.
This special interest group gathers researchers using and developing pharmacological tools to understand and treat neurodegenerative diseases and neurodegeneration following acute conditions like ischemic stroke and traumatic brain injuries. We combine pharmacological studies with investigations into the mechanisms of action of different treatments.
In alignment with MultiPark's strategic goals
- To span from internationally leading pre-clinical research to translational and multidisciplinary clinical research across the spectrum of the main neurodegenerative diseases.
- To create new therapeutic approaches for prevention, disease modification and management of unmet medical needs.
Overarching goals
- Develop pharmacological treatment principles for neurodegenerative diseases and related brain disorders.
- Foster a translational and integrative approach that can bridge experimental and clinical pharmacology.
- Exploit pharmacological tools to advance mechanism-oriented research.
Planned activities
- Biannual meetings to discuss common interests and initiatives.
- More targeted meetings on demand to accelerate the development of strategically important projects.
- Outreaching seminars and workshops, possibly involving MultiPark-supported infrastructures or other special interest groups. (topic example: drug candidates identification, validation, and testing in animal models).
- Joint activities with the Multipark innovation group (e.g. seminars about protection of intellectual properties and developing discoveries).
Convening person
Karsten Ruscher
Researcher